American Well [AMWL] vs Health Catalyst [HCAT] Detailed Stock Comparison
American Well
NYSE
Loading...
Health Catalyst
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: American Well wins in 8 metrics, Health Catalyst wins in 10 metrics, with 0 ties. Health Catalyst appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | American Well | Health Catalyst | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.50 | -2.94 | Health Catalyst |
| Price-to-Book Ratio | 0.40 | 0.68 | American Well |
| Debt-to-Equity Ratio | 2.17 | 49.72 | American Well |
| PEG Ratio | 0.01 | -0.02 | Health Catalyst |
| EV/EBITDA | 0.92 | -17.50 | Health Catalyst |
| Profit Margin (TTM) | -46.16% | -31.67% | Health Catalyst |
| Operating Margin (TTM) | -28.74% | -14.45% | Health Catalyst |
| Return on Equity | -37.62% | -28.42% | Health Catalyst |
| Return on Assets (TTM) | -17.93% | -4.99% | Health Catalyst |
| Free Cash Flow (TTM) | $-142.56M | $-1.84M | Health Catalyst |
| 1-Year Return | -11.98% | -53.64% | American Well |
| Price-to-Sales Ratio (TTM) | 0.42 | 0.75 | American Well |
| Enterprise Value | $-87.96M | $313.31M | Health Catalyst |
| EV/Revenue Ratio | -0.33 | 0.99 | American Well |
| Gross Profit Margin (TTM) | 56.07% | 47.37% | American Well |
| Revenue per Share (TTM) | $17 | $5 | American Well |
| Earnings per Share (Diluted) | $-8.03 | $-1.55 | Health Catalyst |
| Beta (Stock Volatility) | 1.28 | 1.54 | American Well |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
American Well vs Health Catalyst Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| American Well | 3.87% | 1.16% | -17.69% | 0.87% | -20.23% | -0.85% |
| Health Catalyst | 2.42% | -0.29% | -11.52% | -11.98% | -25.71% | -53.95% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| American Well | -11.98% | -91.94% | -98.48% | -98.48% | -98.48% | -98.48% |
| Health Catalyst | -53.64% | -70.71% | -90.20% | -91.17% | -91.17% | -91.17% |
Performance & Financial Health Analysis: American Well vs Health Catalyst
| Metric | AMWL | HCAT |
|---|---|---|
| Market Information | ||
| Market Cap | $112.74M | $237.86M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 58,190 | 1,018,846 |
| 90 Day Avg. Volume | 63,940 | 968,122 |
| Last Close | $6.98 | $3.38 |
| 52 Week Range | $6.09 - $12.95 | $2.52 - $9.24 |
| % from 52W High | -46.10% | -63.42% |
| All-Time High | $875.00 (Jan 25, 2021) | $59.50 (Jun 07, 2021) |
| % from All-Time High | -99.20% | -94.32% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.06% |
| Quarterly Earnings Growth | 0.13% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.46% | -0.32% |
| Operating Margin (TTM) | -0.29% | -0.14% |
| Return on Equity (TTM) | -0.38% | -0.28% |
| Debt to Equity (MRQ) | 2.17 | 49.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $17.56 | $4.95 |
| Cash per Share (MRQ) | $13.56 | $1.38 |
| Operating Cash Flow (TTM) | $-75,621,000 | $-6,036,000 |
| Levered Free Cash Flow (TTM) | $-16,141,000 | $8.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: American Well vs Health Catalyst
| Metric | AMWL | HCAT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.50 | -2.94 |
| Forward P/E | -0.91 | 8.05 |
| PEG Ratio | 0.01 | -0.02 |
| Price to Sales (TTM) | 0.42 | 0.75 |
| Price to Book (MRQ) | 0.40 | 0.68 |
| Market Capitalization | ||
| Market Capitalization | $112.74M | $237.86M |
| Enterprise Value | $-87,956,408 | $313.31M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -0.33 | 0.99 |
| Enterprise to EBITDA | 0.92 | -17.50 |
| Risk & Other Metrics | ||
| Beta | 1.28 | 1.54 |
| Book Value per Share (MRQ) | $17.56 | $4.95 |
Financial Statements Comparison: American Well vs Health Catalyst
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMWL | HCAT |
|---|---|---|
| Revenue/Sales | $66.83M | $79.41M |
| Cost of Goods Sold | $31.57M | $43.18M |
| Gross Profit | $35.26M | $36.24M |
| Research & Development | $22.10M | $15.19M |
| Operating Income (EBIT) | $-30.41M | $-20.17M |
| EBITDA | $-33.32M | $-3.89M |
| Pre-Tax Income | $-17.01M | $-23.53M |
| Income Tax | $568,000 | $215,000 |
| Net Income (Profit) | $-18.36M | $-23.74M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMWL | HCAT |
|---|---|---|
| Cash & Equivalents | $222.41M | $341.97M |
| Total Current Assets | $311.50M | $422.72M |
| Total Current Liabilities | $106.73M | $339.56M |
| Long-Term Debt | $3.57M | $167.04M |
| Total Shareholders Equity | $305.77M | $376.81M |
| Retained Earnings | $-1.98B | $-1.21B |
| Property, Plant & Equipment | $6.72M | $11.88M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMWL | HCAT |
|---|---|---|
| Operating Cash Flow | $-5.33M | $-380,000 |
| Capital Expenditures | $-9,000 | $-663,000 |
| Free Cash Flow | $-25.12M | $-5.05M |
| Debt Repayment | N/A | $-407,000 |
| Common Stock Repurchase | $-1,000 | $-5.00M |
Short Interest & Institutional Ownership Analysis
| Metric | AMWL | HCAT |
|---|---|---|
| Shares Short | 162,811 | 4.90M |
| Short Ratio | 2.19 | 6.23 |
| Short % of Float | 0.01% | 0.08% |
| Average Daily Volume (10 Day) | 58,190 | 1,018,846 |
| Average Daily Volume (90 Day) | 63,940 | 968,122 |
| Shares Outstanding | 15.57M | 64.04M |
| Float Shares | 12.35M | 64.28M |
| % Held by Insiders | 0.06% | 0.03% |
| % Held by Institutions | 0.44% | 0.80% |
Dividend Analysis & Yield Comparison: American Well vs Health Catalyst
| Metric | AMWL | HCAT |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |